HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, announced today that an overview of the Company’s business strategy will be given at the UBS Global Life Sciences Conference, being held at the Grand Hyatt Hotel in New York City. The Spectrum Pharmaceuticals presentation is at 11:30am Eastern Time on Monday, September 19, 2011, in Ballroom I.
